Stephanie Kielb1, Emily Rogalski2, Sandra Weintraub3, Alfred Rademaker4. 1. Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Department of Psychiatry and Behavioral Sciences, Division of Clinical Psychology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Electronic address: stephaniekielb2012@u.northwestern.edu. 2. Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 3. Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Department of Psychiatry and Behavioral Sciences, Division of Clinical Psychology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 4. Cognitive Neurology and Alzheimer's Disease Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Abstract
INTRODUCTION: Functional and cognitive features of subjective cognitive decline (SCD) were identified in a longitudinal database from the National Alzheimer's Coordinating Center. METHODS: Cognitively normal older adults with (SCD+) and without (SCD-) self-reported memory complaints (N = 3915) were compared on (1) baseline Functional Assessment Questionnaire ratings, (2) baseline scores and longitudinal rate of change estimates from nine neuropsychological tests, and (3) final clinical diagnoses. RESULTS: SCD+ had higher baseline ratings of functional impairment, reduced episodic memory practice effects and poorer performance on neuropsychological tests of psychomotor speed and language, and higher frequencies of mild cognitive impairment and dementia diagnoses at the end of follow-up compared with the SCD-group. DISCUSSION: Subtle clinical features of SCD identified in this large cohort are difficult to detect at the individual level. More sensitive tests are needed to identify those with SCD who are vulnerable to cognitive decline and dementia.
INTRODUCTION: Functional and cognitive features of subjective cognitive decline (SCD) were identified in a longitudinal database from the National Alzheimer's Coordinating Center. METHODS: Cognitively normal older adults with (SCD+) and without (SCD-) self-reported memory complaints (N = 3915) were compared on (1) baseline Functional Assessment Questionnaire ratings, (2) baseline scores and longitudinal rate of change estimates from nine neuropsychological tests, and (3) final clinical diagnoses. RESULTS:SCD+ had higher baseline ratings of functional impairment, reduced episodic memory practice effects and poorer performance on neuropsychological tests of psychomotor speed and language, and higher frequencies of mild cognitive impairment and dementia diagnoses at the end of follow-up compared with the SCD-group. DISCUSSION: Subtle clinical features of SCD identified in this large cohort are difficult to detect at the individual level. More sensitive tests are needed to identify those with SCD who are vulnerable to cognitive decline and dementia.
Authors: Laura A Rabin; Colette M Smart; Paul K Crane; Rebecca E Amariglio; Lorin M Berman; Mercé Boada; Rachel F Buckley; Gaël Chételat; Bruno Dubois; Kathryn A Ellis; Katherine A Gifford; Angela L Jefferson; Frank Jessen; Mindy J Katz; Richard B Lipton; Tobias Luck; Paul Maruff; Michelle M Mielke; José Luis Molinuevo; Farnia Naeem; Audrey Perrotin; Ronald C Petersen; Lorena Rami; Barry Reisberg; Dorene M Rentz; Steffi G Riedel-Heller; Shannon L Risacher; Octavio Rodriguez; Perminder S Sachdev; Andrew J Saykin; Melissa J Slavin; Beth E Snitz; Reisa A Sperling; Caroline Tandetnik; Wiesje M van der Flier; Michael Wagner; Steffen Wolfsgruber; Sietske A M Sikkes Journal: J Alzheimers Dis Date: 2015-09-24 Impact factor: 4.472
Authors: Simone Hollands; Yen Ying Lim; Rachel Buckley; Robert H Pietrzak; Peter J Snyder; David Ames; Kathryn A Ellis; Karra Harrington; Nicola Lautenschlager; Ralph N Martins; Colin L Masters; Victor L Villemagne; Christopher C Rowe; Paul Maruff Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: Zvinka Z Zlatar; Raeanne C Moore; Barton W Palmer; Wesley K Thompson; Dilip V Jeste Journal: J Geriatr Psychiatry Neurol Date: 2014-03-10 Impact factor: 2.680
Authors: Kevin Duff; Taylor J Atkinson; Kayla R Suhrie; Bonnie C Allred Dalley; Sydney Y Schaefer; Dustin B Hammers Journal: J Clin Exp Neuropsychol Date: 2016-09-20 Impact factor: 2.475
Authors: Frank Jessen; Steffen Wolfsgruber; Birgitt Wiese; Horst Bickel; Edelgard Mösch; Hanna Kaduszkiewicz; Michael Pentzek; Steffi G Riedel-Heller; Tobias Luck; Angela Fuchs; Siegfried Weyerer; Jochen Werle; Hendrik van den Bussche; Martin Scherer; Wolfgang Maier; Michael Wagner Journal: Alzheimers Dement Date: 2013-01-30 Impact factor: 21.566
Authors: Sandra Weintraub; David Salmon; Nathaniel Mercaldo; Steven Ferris; Neill R Graff-Radford; Helena Chui; Jeffrey Cummings; Charles DeCarli; Norman L Foster; Douglas Galasko; Elaine Peskind; Woodrow Dietrich; Duane L Beekly; Walter A Kukull; John C Morris Journal: Alzheimer Dis Assoc Disord Date: 2009 Apr-Jun Impact factor: 2.703
Authors: Zvinka Z Zlatar; Martha C Muniz; Sarah G Espinoza; Roberto Gratianne; Tamar H Gollan; Douglas Galasko; David P Salmon Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Nikki L Hill; Jacqueline Mogle; Sakshi Bhargava; Emily Whitaker; Iris Bhang; Ana W Capuano; Zoe Arvanitakis; David A Bennett; Lisa L Barnes Journal: J Gerontol B Psychol Sci Soc Sci Date: 2020-03-09 Impact factor: 4.077
Authors: Samantha E John; Sarah A Evans; John Hanfelt; David W Loring; Felicia C Goldstein Journal: J Geriatr Psychiatry Neurol Date: 2019-08-13 Impact factor: 2.680
Authors: Fabian W Corlier; Crystal Shaw; Eleanor Hayes-Larson; Dan Mungas; Sarah Tomaszewski Farias; M Maria Glymour; Rachel A Whitmer; Elizabeth R Mayeda Journal: Alzheimer Dis Assoc Disord Date: 2020 Jul-Sep Impact factor: 2.357